Role of HDAC inhibitors in diabetes mellitus
- PMID: 31477543
- DOI: 10.1016/j.retram.2019.08.001
Role of HDAC inhibitors in diabetes mellitus
Abstract
Objective: The role of histone deacetylases has come out as an emerging remedy in control and treatment of various metabolic disorders and cancers. This review highlights their intricate role in diabetes mellitus as well as its associated complications.
Key findings: Through recent studies and reports the role of various epigenetic markers in treatment of diabetes mellitus has been revealed. HDAC enzyme regulates the structure of chromatin and transcripts genes in the nucleus synthesizing various proteins that control metabolic activities in the body. It mainly acts by removing an acetyl group from its precursor protein thereby modulating gene expression and regulates the metabolic enzyme acetylation in mitochondria and cytosol.
Summary: The present review focus on the intrinsic role of HDAC inhibitors as an emerging remedy for diabetes and its complications demonstrating their use in preventing resistance of β-cells towards insulin, destruction of β-cells and provide protection against cytokine mediated attack on pancreatic cells.
Keywords: Acetylation; Gene expression; Histone deacetylases; Insulin resistance; Transcription; β-cell destruction.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.
Similar articles
-
HDAC4: an emerging target in diabetes mellitus and diabetic complications.Eur J Med Res. 2025 May 30;30(1):429. doi: 10.1186/s40001-025-02697-y. Eur J Med Res. 2025. PMID: 40448151 Free PMC article. Review.
-
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.Life Sci. 2021 Jul 15;277:119504. doi: 10.1016/j.lfs.2021.119504. Epub 2021 Apr 16. Life Sci. 2021. PMID: 33872660 Review.
-
Phenylbutyrate and β-cell function: contribution of histone deacetylases and ER stress inhibition.Epigenomics. 2017 May;9(5):711-720. doi: 10.2217/epi-2016-0160. Epub 2017 May 4. Epigenomics. 2017. PMID: 28470097 Review.
-
Targeting histone deacetylases for the treatment of disease.J Cell Mol Med. 2009 May;13(5):826-52. doi: 10.1111/j.1582-4934.2008.00571.x. Epub 2008 Nov 3. J Cell Mol Med. 2009. PMID: 19175682 Free PMC article. Review.
-
HDACs and HDAC Inhibitors in Cancer Development and Therapy.Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):a026831. doi: 10.1101/cshperspect.a026831. Cold Spring Harb Perspect Med. 2016. PMID: 27599530 Free PMC article. Review.
Cited by
-
Epigenetic modifications in pancreas development, diabetes, and therapeutics.Med Res Rev. 2022 May;42(3):1343-1371. doi: 10.1002/med.21878. Epub 2022 Jan 4. Med Res Rev. 2022. PMID: 34984701 Free PMC article. Review.
-
Research Progress on the Correlation Between Hypertension and Gut Microbiota.J Multidiscip Healthc. 2024 May 16;17:2371-2387. doi: 10.2147/JMDH.S463880. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38770171 Free PMC article. Review.
-
HDAC4: an emerging target in diabetes mellitus and diabetic complications.Eur J Med Res. 2025 May 30;30(1):429. doi: 10.1186/s40001-025-02697-y. Eur J Med Res. 2025. PMID: 40448151 Free PMC article. Review.
-
Epigenetic Regulation of Pancreas Development and Function.Adv Anat Embryol Cell Biol. 2024;239:1-30. doi: 10.1007/978-3-031-62232-8_1. Adv Anat Embryol Cell Biol. 2024. PMID: 39283480 Review.
-
Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia.Br J Clin Pharmacol. 2022 Dec;88(12):5238-5256. doi: 10.1111/bcp.15428. Epub 2022 Jul 11. Br J Clin Pharmacol. 2022. PMID: 35655123 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical